[TVTX] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[TVTX] Travere Therapeutics, Inc.
Announcement Date
04-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -176.90%
YoY- -135.15%
Quarter Report
TVTX's Result
TVTX's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 38,800 33,620 37,326 33,945 33,311 29,008 30,447 17.55%
PBT -15,154 -13,154 -12,288 -30,646 -20,795 6,146 -12,994 10.80%
Tax -1,925 -2,064 -3,685 6,467 -7,392 -5,070 -10,525 -67.81%
NP -13,229 -11,090 -8,603 -37,113 -13,403 11,216 -2,469 206.51%
Tax Rate - - - - - 82.49% - -
Total Cost 52,029 44,710 45,929 71,058 46,714 17,792 32,916 35.73%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin -34.10 -32.99 -23.05 -109.33 -40.24 38.67 -8.11 160.73%
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -0.34 -0.29 -0.23 -1.00 -0.37 0.31 -0.07 187.08%
EPS Diluted -0.34 -0.28 -0.22 -1.00 -0.37 -0.08 -0.07 187.08%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.